Biotech Values

[DewDiligence]

(EPRS)—When a company such as ZLCS completely and utterly fails and is left with a corporate shell, a Nasdaq listing, and a smidgen of cash, it's only natural that some private company will want to take the opportunity to go public via a reverse merger. It's cheaper and faster than a conventional IPO, and the pricing terms can be worked out between the parties without having to sell the business plan to public investors.